GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (XSWX:NOBN) » Definitions » Piotroski F-Score

Nobel Biocare Holding AG (XSWX:NOBN) Piotroski F-Score : 0 (As of Jun. 17, 2024)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Nobel Biocare Holding AG has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Nobel Biocare Holding AG's Piotroski F-Score or its related term are showing as below:


Nobel Biocare Holding AG Piotroski F-Score Historical Data

The historical data trend for Nobel Biocare Holding AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Piotroski F-Score Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.00 5.00 6.00 6.00

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.00 5.00 6.00 6.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec13) TTM:Last Year (Dec12) TTM:
Net Income was CHF52.1 Mil.
Cash Flow from Operations was CHF95.2 Mil.
Revenue was CHF693.6 Mil.
Gross Profit was CHF526.6 Mil.
Average Total Assets from the begining of this year (Dec12)
to the end of this year (Dec13) was (726.687 + 746.364) / 2 = CHF736.5255 Mil.
Total Assets at the begining of this year (Dec12) was CHF726.7 Mil.
Long-Term Debt & Capital Lease Obligation was CHF120.2 Mil.
Total Current Assets was CHF414.5 Mil.
Total Current Liabilities was CHF168.6 Mil.
Net Income was CHF55.7 Mil.

Revenue was CHF701.8 Mil.
Gross Profit was CHF531.4 Mil.
Average Total Assets from the begining of last year (Dec11)
to the end of last year (Dec12) was (727.377 + 726.687) / 2 = CHF727.032 Mil.
Total Assets at the begining of last year (Dec11) was CHF727.4 Mil.
Long-Term Debt & Capital Lease Obligation was CHF120.3 Mil.
Total Current Assets was CHF366.0 Mil.
Total Current Liabilities was CHF163.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Nobel Biocare Holding AG's current Net Income (TTM) was 52.1. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Nobel Biocare Holding AG's current Cash Flow from Operations (TTM) was 95.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec12)
=52.104/726.687
=0.07170075

ROA (Last Year)=Net Income/Total Assets (Dec11)
=55.741/727.377
=0.07663289

Nobel Biocare Holding AG's return on assets of this year was 0.07170075. Nobel Biocare Holding AG's return on assets of last year was 0.07663289. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Nobel Biocare Holding AG's current Net Income (TTM) was 52.1. Nobel Biocare Holding AG's current Cash Flow from Operations (TTM) was 95.2. ==> 95.2 > 52.1 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec13)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec12 to Dec13
=120.194/736.5255
=0.16319055

Gearing (Last Year: Dec12)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec11 to Dec12
=120.307/727.032
=0.1654769

Nobel Biocare Holding AG's gearing of this year was 0.16319055. Nobel Biocare Holding AG's gearing of last year was 0.1654769. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec13)=Total Current Assets/Total Current Liabilities
=414.479/168.611
=2.45819668

Current Ratio (Last Year: Dec12)=Total Current Assets/Total Current Liabilities
=366.034/163.191
=2.24297909

Nobel Biocare Holding AG's current ratio of this year was 2.45819668. Nobel Biocare Holding AG's current ratio of last year was 2.24297909. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Nobel Biocare Holding AG's number of shares in issue this year was 123.435. Nobel Biocare Holding AG's number of shares in issue last year was 123.055. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=526.58/693.578
=0.75922247

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=531.437/701.838
=0.7572075

Nobel Biocare Holding AG's gross margin of this year was 0.75922247. Nobel Biocare Holding AG's gross margin of last year was 0.7572075. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec12)
=693.578/726.687
=0.95443843

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec11)
=701.838/727.377
=0.96488891

Nobel Biocare Holding AG's asset turnover of this year was 0.95443843. Nobel Biocare Holding AG's asset turnover of last year was 0.96488891. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Nobel Biocare Holding AG has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Nobel Biocare Holding AG  (XSWX:NOBN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Nobel Biocare Holding AG Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (XSWX:NOBN) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (XSWX:NOBN) Headlines

No Headlines